Form D · Other
iMedX Holdings, Inc.
Atlanta, GA · CIK 0001531763
Offering snapshot reported Dec 24, 2013 · SEC filing
- Reported sold
- $4.03M Offering amount: $4.03M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 11, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 24, 2013 | Initial | $4,034,263 | No comparison | 6 | SEC filing |
| Oct 5, 2011 | Initial | $950,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-208698
Source: Form D, filed Dec 24, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ramesh Alur | Director |
| Robert Attanasio | Executive |
| David Cohen | Director |
| Christopher Foley | Director, Executive |
| Michael J. Foster | Director |
| Michael Kimball | Director |
| James A. Parsons | Director |
| R. Peter Reiter | Director |
| Michael W. Rubel | Director |
| Venkat Sharma | Director |
Issuer details
Industry: Other (See others in industry)
Address:
6 Concourse Parkway, Suite 1475
Atlanta, GA, 30328
Atlanta, GA, 30328